Neoplasms (Oncology)
At Klinikum Wuerzburg Mitte gGmbH, investigators are studying metastatic non‑small cell lung cancer with the aim of testing new targeted agents and immunotherapy combinations to improve survival outcomes.
- Evaluation of ROS1‑positive tumor targeting therapies
- Combination of checkpoint inhibitors with antibody‑drug conjugates
- Assessment of progression‑free survival as a primary endpoint
- Comparison of overall survival benefits across treatment arms
Results are expected to shape future lung‑cancer treatment guidelines and provide new options for patients with advanced disease.
Nervous System Diseases
The research team is also dedicated to advancing care for multiple sclerosis, focusing on the long‑term safety and tolerability of oral therapies for both relapsing and progressive forms of the disease.
- Long‑term safety monitoring of BTK inhibitor treatment
- Inclusion of relapsing‑remitting and progressive patient cohorts
- Evaluation of neurological function preservation
- Impact on patients’ quality of life and daily activities
Findings will help clinicians choose safer, more effective strategies for managing chronic nervous‑system disorders.
